Late-phase human herpesvirus 6B reactivation in hematopoietic stem cell transplant recipients.
Hiroki MiuraYoshiki KawamuraFumihiko HattoriMakito TanakaKazuko KudoMasaru IhiraHiroshi YatsuyaYoshiyuki TakahashiSeiji KojimaTetsushi YoshikawaPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2018)
Late-phase HHV-6B infection in HSCT recipients was associated with worse outcomes. The full spectrum of clinical features of the infection has not been fully elucidated, and therefore, recipients with high-risk factors for late-phase HHV-6B infection should be carefully monitored.